Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/25 16:01 | 10/14/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Militello John | NJ | O | See Rema | 12 | S.m | -259 | 5.57 | 0 | -46 | 67 | D | |||||||||||||||
8/20/25 17:00 | 8/18/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Schwartz Jonathan David | NJ | O | See Rema | 5 | S.m | -281 | 9.02 | 0 | -31 | 238 | D | |||||||||||||||
8/20/25 17:00 | 8/18/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Wilson Martin | NJ | O | GC | 7 | S.m | -120 | 5.80 | 0 | -21 | 151 | D | |||||||||||||||
7/8/25 16:05 | 7/3/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Ondrey Aaron | NJ | O | CFO | 2 | S | -44 | 4.90 | 0 | -9 | 130 | D | |||||||||||||||
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Patel Kinnari | NJ | O | See Rema | 5 | S | -212 | 12.60 | 0 | -17 | 574 | D | |||||||||||||||
5/22/25 16:05 | 5/20/25 | RCKT | Health | Drug | Pharmaceutical Preparations | Shah Gaurav | NJ | DO | CEO | 5 | S | -534 | 12.44 | 0 | -43 | 1,195 | D | |||||||||||||||
11/4/24 16:06 | 10/31/24 | RCKT | Health | Drug | Pharmaceutical Preparations | White Mark Andrew | NJ | O | See Rema | 2 | S | -113 | 18.49 | 0 | -6 | 72 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |